HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Al-Lawati, J. A. Articles by Jousilahti, P. Search for Related Content PubMed PubMed Citation Articles by Al-Lawati, J. A. Articles by Jousilahti, P. Social Bookmarking                What's this?

Prevalence of the Metabolic Syndrome Among Omani Adults

¹ Ministry of Health, Non-communicable Diseases, Muscat, Muscat, Oman
² University of Helsinki, Department of Public Health, Helsinki, Finland

OBJECTIVE—To estimate the prevalence of the metabolic syndrome by age and sex in the Omani population as defined by the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III [ATP III]) of North America.

RESEARCH DESIGN AND METHODS—We analyzed data from a cross-sectional survey conducted in 2001 containing a probability random sample of 1,419 Omani adults aged 20 years living in the city of Nizwa. The metabolic syndrome, defined by the ATP III, was defined as having three or more of the following abnormalities: waist circumference >102 cm in men and >88 cm in women, serum triglycerides 150 mg/dl (1.69 mmol/l), HDL cholesterol <40 mg/dl (1.04 mmol/l) in men and <50 mg/dl (1.29 mmol/l) in women, systolic blood pressure 130 mmHg and/or diastolic 85 mmHg or on treatment for hypertension, and fasting serum glucose 110 mg/dl (6.1 mmol/l) or on treatment for diabetes.

RESULTS—The age-adjusted prevalence of the metabolic syndrome was 21.0%. The crude prevalence was slightly lower (17.0%). The age-adjusted prevalence was 19.5% among men and 23.0% among women (P = 0.236). Low HDL cholesterol was the most common component (75.4%) of the metabolic syndrome among the study population followed by abdominal obesity (24.6%). Abdominal obesity was markedly higher in women (44.3%) than in men (4.7%).

CONCLUSIONS—The prevalence of the metabolic syndrome in Oman is similar to that in developed countries. Future prevention and control strategies should not overlook the importance of noncommunicable disease risk factors in rapidly developing countries.

Abbreviations: ATP III, Adult Treatment Panel III • CEA, Census Enumeration Area • CVD, cardiovascular disease • FPG, fasting plasma glucose

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Kelishadi Childhood Overweight, Obesity, and the Metabolic Syndrome in Developing Countries Epidemiol. Rev., May 3, 2007; (2007) mxm003v1. [Abstract] [Full Text] [PDF]

				S. M. Grundy, J. I. Cleeman, S. R. Daniels, K. A. Donato, R. H. Eckel, B. A. Franklin, D. J. Gordon, R. M. Krauss, P. J. Savage, S. C. Smith Jr, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation, October 25, 2005; 112(17): 2735 - 2752. [Full Text] [PDF]

				R. D. Freire, M. A. Cardoso, S. G.A. Gimeno, S. R.G. Ferreira, and for the Japanese-Brazilian Diabetes Study Group Dietary Fat Is Associated With Metabolic Syndrome in Japanese Brazilians Diabetes Care, July 1, 2005; 28(7): 1779 - 1785. [Abstract] [Full Text] [PDF]

				S. Lim, K. S. Park, H. K. Lee, and S.-I. Cho Changes in the Characteristics of Metabolic Syndrome in Korea Over the Period 1998-2001 as Determined by Korean National Health and Nutrition Examination Surveys Diabetes Care, July 1, 2005; 28(7): 1810 - 1812. [Full Text] [PDF]

				C. Jerico, H. Knobel, M. Montero, J. Ordonez-Llanos, A. Guelar, J. L. Gimeno, P. Saballs, J. L. Lopez-Colomes, and J. Pedro-Botet Metabolic Syndrome Among HIV-Infected Patients: Prevalence, characteristics, and related factors Diabetes Care, January 1, 2005; 28(1): 132 - 137. [Abstract] [Full Text] [PDF]

				M. Y. Alenezi, M. Marcil, D. Blank, M. Sherman, and J. Genest Jr. Is the Decreased High-Density Lipoprotein Cholesterol in the Metabolic Syndrome Due to Cellular Lipid Efflux Defect? J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 761 - 764. [Abstract] [Full Text] [PDF]

				L. A. Jaber, M. B. Brown, A. Hammad, Q. Zhu, and W. H. Herman The Prevalence of the Metabolic Syndrome Among Arab Americans Diabetes Care, January 1, 2004; 27(1): 234 - 238. [Abstract] [Full Text] [PDF]